Skip to main content
Top
Published in: Annals of Nuclear Medicine 8/2022

Open Access 07-07-2022 | Artificial Intelligence | Original Article

Diagnosis of Parkinson syndrome and Lewy-body disease using 123I-ioflupane images and a model with image features based on machine learning

Authors: Kenichi Nakajima, Shintaro Saito, Zhuoqing Chen, Junji Komatsu, Koji Maruyama, Naoki Shirasaki, Satoru Watanabe, Anri Inaki, Kenjiro Ono, Seigo Kinuya

Published in: Annals of Nuclear Medicine | Issue 8/2022

Login to get access

Abstract

Objectives

123I-ioflupane has been clinically applied to dopamine transporter imaging and visual interpretation assisted by region-of-interest (ROI)-based parameters. We aimed to build a multivariable model incorporating machine learning (ML) that could accurately differentiate abnormal profiles on 123I-ioflupane images and diagnose Parkinson syndrome or disease and dementia with Lewy bodies (PS/PD/DLB).

Methods

We assessed 123I-ioflupane images from 239 patients with suspected neurodegenerative diseases or dementia and classified them as having PS/PD/DLB or non-PS/PD/DLB. The image features of high or low uptake (F1), symmetry or asymmetry (F2), and comma- or dot-like patterns of caudate and putamen uptake (F3) were analyzed on 137 images from one hospital for training. Direct judgement of normal or abnormal profiles (F4) was also examined. Machine learning methods included logistic regression (LR), k-nearest neighbors (kNNs), and gradient boosted trees (GBTs) that were assessed using fourfold cross-validation. We generated the following multivariable models for the test database (n = 102 from another hospital): Model 1, ROI-based measurements of specific binding ratios and asymmetry indices; Model 2, ML-based judgement of abnormalities (F4); and Model 3, features F1, F2 and F3, plus patient age. Diagnostic accuracy was compared using areas under receiver-operating characteristics curves (AUC).

Results

The AUC was high with all ML methods (0.92–0.96) for high or low uptake. The AUC was the highest for symmetry or asymmetry with the kNN method (AUC 0.75) and the comma-dot feature with the GBT method (AUC 0.94). Based on the test data set, the diagnostic accuracy for a diagnosis of PS/PD/DLB was 0.86 ± 0.04 (SE), 0.87 ± 0.04, and 0.93 ± 0.02 for Models 1, 2 and 3, respectively. The AUC was optimal for Model 3, and significantly differed between Models 3 and 1 (p = 0.027), and 3 and 2 (p = 0.029).

Conclusions

Image features such as high or low uptake, symmetry or asymmetry, and comma- or dot-like profiles can be determined using ML. The diagnostic accuracy of differentiating PS/PD/DLB was the highest for the multivariate model with three features and age compared with the conventional ROI-based method.
Appendix
Available only for authorised users
Literature
1.
go back to reference Catafau AM, Tolosa E, Da TCUPSSG. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord. 2004;19:1175–82.CrossRef Catafau AM, Tolosa E, Da TCUPSSG. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord. 2004;19:1175–82.CrossRef
2.
go back to reference Tolosa E, Borght TV, Moreno E, Da TCUPSSG. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study. Mov Disord. 2007;22:2346–51.CrossRef Tolosa E, Borght TV, Moreno E, Da TCUPSSG. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study. Mov Disord. 2007;22:2346–51.CrossRef
3.
go back to reference McKeith I, O’Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305–13.CrossRef McKeith I, O’Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305–13.CrossRef
4.
go back to reference Al’Aref SJ, Anchouche K, Singh G, Slomka PJ, Kolli KK, Kumar A, et al. Clinical applications of machine learning in cardiovascular disease and its relevance to cardiac imaging. Eur Heart J. 2019;40:1975–86.CrossRef Al’Aref SJ, Anchouche K, Singh G, Slomka PJ, Kolli KK, Kumar A, et al. Clinical applications of machine learning in cardiovascular disease and its relevance to cardiac imaging. Eur Heart J. 2019;40:1975–86.CrossRef
5.
go back to reference Kobayashi Y, Ishibashi M, Kobayashi H. How will “democratization of artificial intelligence” change the future of radiologists? Jpn J Radiol. 2019;37:9–14.CrossRef Kobayashi Y, Ishibashi M, Kobayashi H. How will “democratization of artificial intelligence” change the future of radiologists? Jpn J Radiol. 2019;37:9–14.CrossRef
6.
go back to reference Quer G, Arnaout R, Henne M, Arnaout R. machine learning and the future of cardiovascular care: JACC state-of-the-art review. J Am Coll Cardiol. 2021;77:300–13.CrossRef Quer G, Arnaout R, Henne M, Arnaout R. machine learning and the future of cardiovascular care: JACC state-of-the-art review. J Am Coll Cardiol. 2021;77:300–13.CrossRef
7.
go back to reference Nakajima K, Edenbrandt L, Mizokami A. Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer. Int J Urol. 2017;24:668–73.CrossRef Nakajima K, Edenbrandt L, Mizokami A. Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer. Int J Urol. 2017;24:668–73.CrossRef
8.
go back to reference Nakajima K, Kudo T, Nakata T, Kiso K, Kasai T, Taniguchi Y, et al. Diagnostic accuracy of an artificial neural network compared with statistical quantitation of myocardial perfusion images: a Japanese multicenter study. Eur J Nucl Med Mol Imaging. 2017;44:2280–9.CrossRef Nakajima K, Kudo T, Nakata T, Kiso K, Kasai T, Taniguchi Y, et al. Diagnostic accuracy of an artificial neural network compared with statistical quantitation of myocardial perfusion images: a Japanese multicenter study. Eur J Nucl Med Mol Imaging. 2017;44:2280–9.CrossRef
9.
go back to reference Nakajima K, Okuda K, Watanabe S, Matsuo S, Kinuya S, Toth K, et al. Artificial neural network retrained to detect myocardial ischemia using a Japanese multicenter database. Ann Nucl Med. 2018;32:303–10.CrossRef Nakajima K, Okuda K, Watanabe S, Matsuo S, Kinuya S, Toth K, et al. Artificial neural network retrained to detect myocardial ischemia using a Japanese multicenter database. Ann Nucl Med. 2018;32:303–10.CrossRef
10.
go back to reference Magesh PR, Myloth RD, Tom RJ. An explainable machine learning model for early detection of Parkinson’s disease using LIME on DaTSCAN imagery. Comput Biol Med. 2020;126: 104041.CrossRef Magesh PR, Myloth RD, Tom RJ. An explainable machine learning model for early detection of Parkinson’s disease using LIME on DaTSCAN imagery. Comput Biol Med. 2020;126: 104041.CrossRef
11.
go back to reference Iwabuchi Y, Nakahara T, Kameyama M, Yamada Y, Hashimoto M, Matsusaka Y, et al. Impact of a combination of quantitative indices representing uptake intensity, shape, and asymmetry in DAT SPECT using machine learning: comparison of different volume of interest settings. EJNMMI Res. 2019;9:7.CrossRef Iwabuchi Y, Nakahara T, Kameyama M, Yamada Y, Hashimoto M, Matsusaka Y, et al. Impact of a combination of quantitative indices representing uptake intensity, shape, and asymmetry in DAT SPECT using machine learning: comparison of different volume of interest settings. EJNMMI Res. 2019;9:7.CrossRef
12.
go back to reference Tang J, Yang B, Adams MP, Shenkov NN, Klyuzhin IS, Fotouhi S, et al. Artificial neural network-based prediction of outcome in parkinson’s disease patients using DaTscan SPECT imaging features. Mol Imaging Biol. 2019;21:1165–73.CrossRef Tang J, Yang B, Adams MP, Shenkov NN, Klyuzhin IS, Fotouhi S, et al. Artificial neural network-based prediction of outcome in parkinson’s disease patients using DaTscan SPECT imaging features. Mol Imaging Biol. 2019;21:1165–73.CrossRef
13.
go back to reference Tossici-Bolt L, Hoffmann SM, Kemp PM, Mehta RL, Fleming JS. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging. 2006;33:1491–9.CrossRef Tossici-Bolt L, Hoffmann SM, Kemp PM, Mehta RL, Fleming JS. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging. 2006;33:1491–9.CrossRef
14.
go back to reference Otaki Y, Miller RJH, Slomka PJ. The application of artificial intelligence in nuclear cardiology. Ann Nucl Med. 2022;36:111–22.CrossRef Otaki Y, Miller RJH, Slomka PJ. The application of artificial intelligence in nuclear cardiology. Ann Nucl Med. 2022;36:111–22.CrossRef
15.
go back to reference Hirata K, Sugimori H, Fujima N, Toyonaga T, Kudo K. Artificial intelligence for nuclear medicine in oncology. Ann Nucl Med. 2022;36:123–32.CrossRef Hirata K, Sugimori H, Fujima N, Toyonaga T, Kudo K. Artificial intelligence for nuclear medicine in oncology. Ann Nucl Med. 2022;36:123–32.CrossRef
16.
go back to reference Matsuda H, Murata M, Mukai Y, Sako K, Ono H, Toyama H, et al. Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT. Eur J Nucl Med Mol Imaging. 2018;45:1405–16.CrossRef Matsuda H, Murata M, Mukai Y, Sako K, Ono H, Toyama H, et al. Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT. Eur J Nucl Med Mol Imaging. 2018;45:1405–16.CrossRef
17.
go back to reference Kane JPM, Roberts G, Petrides GS, Lloyd JJ, O’Brien JT, Thomas AJ. (123)I-MIBG scintigraphy utility and cut-off value in a clinically representative dementia cohort. Parkinsonism Relat Disord. 2019;62:79–84.CrossRef Kane JPM, Roberts G, Petrides GS, Lloyd JJ, O’Brien JT, Thomas AJ. (123)I-MIBG scintigraphy utility and cut-off value in a clinically representative dementia cohort. Parkinsonism Relat Disord. 2019;62:79–84.CrossRef
18.
go back to reference Sawada H, Orimo S. Relationship between striatal 123I-FP-CIT uptake and cognitive functions in Parkinson’s disease [Japanese, Abstract in English]. Rinsho Shinkeigaku (Clin Neurol). 2019;59:799–805.CrossRef Sawada H, Orimo S. Relationship between striatal 123I-FP-CIT uptake and cognitive functions in Parkinson’s disease [Japanese, Abstract in English]. Rinsho Shinkeigaku (Clin Neurol). 2019;59:799–805.CrossRef
19.
go back to reference Morbelli S, Arnaldi D, Cella E, Raffa S, Donegani MI, Capitanio S, et al. Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools. EJNMMI Res. 2020;10:137.CrossRef Morbelli S, Arnaldi D, Cella E, Raffa S, Donegani MI, Capitanio S, et al. Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools. EJNMMI Res. 2020;10:137.CrossRef
20.
go back to reference Matesan M, Gaddikeri S, Longfellow K, Miyaoka R, Elojeimy S, Elman S, et al. I-123 DaTscan SPECT brain imaging in Parkinsonian syndromes: utility of the putamen-to-caudate ratio. J Neuroimaging. 2018;28:629–34.CrossRef Matesan M, Gaddikeri S, Longfellow K, Miyaoka R, Elojeimy S, Elman S, et al. I-123 DaTscan SPECT brain imaging in Parkinsonian syndromes: utility of the putamen-to-caudate ratio. J Neuroimaging. 2018;28:629–34.CrossRef
21.
go back to reference Prashanth R, Roy SD, Mandal PK, Ghosh S. High-accuracy classification of Parkinson’s disease through shape analysis and surface fitting in 123I-ioflupane SPECT imaging. IEEE J Biomed Health Inform. 2017;21:794–802.CrossRef Prashanth R, Roy SD, Mandal PK, Ghosh S. High-accuracy classification of Parkinson’s disease through shape analysis and surface fitting in 123I-ioflupane SPECT imaging. IEEE J Biomed Health Inform. 2017;21:794–802.CrossRef
22.
go back to reference Kim JS, Oh YS, Kim YI, Yang DW, Chung YA, You Ie R, et al. Combined use of 123I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study. Arch Gerontol Geriatr. 2013;56:124–8.CrossRef Kim JS, Oh YS, Kim YI, Yang DW, Chung YA, You Ie R, et al. Combined use of 123I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study. Arch Gerontol Geriatr. 2013;56:124–8.CrossRef
23.
go back to reference Roberts G, Lloyd JJ, Petrides GS, Donaghy PC, Kane JPM, Durcan R, et al. 123I-FP-CIT striatal binding ratios do not decrease significantly with age in older adults. Ann Nucl Med. 2019;33:434–43.CrossRef Roberts G, Lloyd JJ, Petrides GS, Donaghy PC, Kane JPM, Durcan R, et al. 123I-FP-CIT striatal binding ratios do not decrease significantly with age in older adults. Ann Nucl Med. 2019;33:434–43.CrossRef
24.
go back to reference Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanishi Y, et al. Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol. 2014;21:970–8.CrossRef Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanishi Y, et al. Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol. 2014;21:970–8.CrossRef
Metadata
Title
Diagnosis of Parkinson syndrome and Lewy-body disease using 123I-ioflupane images and a model with image features based on machine learning
Authors
Kenichi Nakajima
Shintaro Saito
Zhuoqing Chen
Junji Komatsu
Koji Maruyama
Naoki Shirasaki
Satoru Watanabe
Anri Inaki
Kenjiro Ono
Seigo Kinuya
Publication date
07-07-2022
Publisher
Springer Nature Singapore
Published in
Annals of Nuclear Medicine / Issue 8/2022
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-022-01759-z

Other articles of this Issue 8/2022

Annals of Nuclear Medicine 8/2022 Go to the issue